{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:02:38Z","timestamp":1769598158136,"version":"3.49.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"name":"Asahi General Hospital","award":["2016111514"],"award-info":[{"award-number":["2016111514"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,17]]},"DOI":"10.1093\/jjco\/hyw186","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T01:25:15Z","timestamp":1484702715000},"page":"257-261","source":"Crossref","is-referenced-by-count":8,"title":["Treatment of locally advanced prostate cancer (Stage T3)"],"prefix":"10.1093","volume":"47","author":[{"given":"Yoshiyasu","family":"Amiya","sequence":"first","affiliation":[{"name":"Department of Urology, Asahi General Hospital, Asahi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Urology, Asahi General Hospital, Asahi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Department of Urology, Asahi General Hospital, Asahi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Urology, Asahi General Hospital, Asahi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Urology, Asahi General Hospital, Asahi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Urology, Asahi General Hospital, Asahi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroomi","family":"Nakatsu","sequence":"additional","affiliation":[{"name":"Department of Urology, Asahi General Hospital, Asahi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shino","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Urology, Asahi General Hospital, Asahi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shimazaki","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"key":"key\n\t\t\t\t2018111909222970300_hyw186C1","author":"NCCN Clinical Practice Guidelines in Oncology","year":"2013"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of clsssifying prognostic comorbidity in longitudinal studies : development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jjco\/hyq032","article-title":"Outcome of patients with localized prostate cancer treated by radiotherapy after confirming the absene of lymph node invasion","volume":"40","author":"Suzuki","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0090-4295(97)00171-4","article-title":"Preliminary results of o prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study on neoadjivant treatment of prostate cncer","volume":"49","author":"Wities","year":"1997","journal-title":"Urology"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1159\/000020366","article-title":"4-year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3 N0M0 prostate cancer. European Study Group on neoadjuvant treatment of prostate cancer","volume":"38","author":"Schulman","year":"2000","journal-title":"Eur Urol"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jcp.55.7.508","article-title":"Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer","volume":"55","author":"Selli","year":"2002","journal-title":"J Clin Pathol"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/01.ju.0000081404.98273.fd","article-title":"Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy","volume":"170","author":"Klotz","year":"2003","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C9","first-page":"CD006019","article-title":"Neo-adjuvant and adjuvant hormone therapy for localized and locally advanced prostate cancer","volume":"18","author":"Kumar","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ctrv.2009.05.001","article-title":"Adjuvant hormone therapy for localized and locally advanced prostate carcinoma : a systemstic review and meta-analysis of randomized trials","volume":"35","author":"Shelley","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00066-016-0990-z","article-title":"Risk of biochemical recurrence and timing of radiotherapy in pT3a N0 prostate cancer with positive surgical margin : a single center experience","volume":"192","author":"Hegemann","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C12","first-page":"155","volume-title":"Radiotherapy of Prostate Cancer","author":"Perez","year":"2000"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":"Long-term results with intermediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study) : a phase III randomized trial","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C14","first-page":"5105","article-title":"Carbon ion radiotherapy for treatment of prostate cancer and subsequent outcomes after biochemical failure","volume":"30","author":"Shimazaki","year":"2010","journal-title":"Anticancer Res"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C15","first-page":"1","article-title":"Hormone therapy in combination with radiotherapy in the treatment of prostate cancer : why and in which group of patients","volume":"19","author":"Milecki","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2011.08.026","article-title":"Comtemporary role of androgen deprivation therapy for proistate cancer","volume":"61","author":"Pagliarulo","year":"2012","journal-title":"Eur Urol"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C17","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/cncr.10977","article-title":"Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleasson score 8 or above","volume":"95","author":"Kupelian","year":"2002","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/iju.12037","article-title":"Japan cancer of the prostate risk assessment for combined androgen blockade including bicalutamide : clinical application and validation","volume":"20","author":"Kitagawa","year":"2013","journal-title":"Int J Urol"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/ijcp.12838","article-title":"Types of chronic conditions combinations and initial cancer treatment among elderly medicare beneficiarities wih localized prostate cancer","volume":"70","author":"Raval","year":"2016","journal-title":"Int J Clin Pract"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0090-4295(99)00106-5","article-title":"Long-term results of a randomized trial for the treatment of stags B2 and C prostate cancer : Radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities","volume":"54","author":"Akakura","year":"1999","journal-title":"Urology"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<425::AID-CNCR25>3.0.CO;2-Z","article-title":"A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and reacted at a single institution","volume":"88","author":"Martinez","year":"2000","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.10657","article-title":"Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era","volume":"95","author":"D'Amoco","year":"2002","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clgc.2014.01.010","article-title":"Radical prostatectomy or radiotherapy in high-risk prostate cancer: a systematic review and metaanalysis","volume":"12","author":"Petrerlli","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eururo.2015.11.010","article-title":"Surgery versus radiotherapy for clinically-localized prostate cancer: a ststematic review and meta-analysis","volume":"70","author":"Wallis","year":"2016","journal-title":"Eur Urol"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C25","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2420786","article-title":"Evolving paradigm of radiotherapy for high-risk prostate cancer: current consensus and continuing controversies","author":"Juloori","year":"2016","journal-title":"Prostate Cancer"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C26","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1245\/s10434-014-3780-9","article-title":"A competing risk analysis of cancer-specific mortality of iitial treatment with radical prostatectomy versus radiation therapy in clinically localized high-ridk prostate cancer","volume":"21","author":"Lee","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"key\n\t\t\t\t2018111909222970300_hyw186C27","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.30184","article-title":"Association of functional status and treatment choice among older men with prostate cancer in the medicare advantage population","author":"Jacobs","year":"2016","journal-title":"Cancer"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/47\/3\/257\/26648806\/hyw186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T17:42:12Z","timestamp":1568742132000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/47\/3\/257\/2911853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,1,17]]},"published-print":{"date-parts":[[2017,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyw186","relation":{},"ISSN":["0368-2811","1465-3621"],"issn-type":[{"value":"0368-2811","type":"print"},{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,3]]},"published":{"date-parts":[[2017,1,17]]}}}